semaglutide tirzepatide weight loss injections In adults with obesity but not diabetes, leads to significantly greater than over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL Semaglutide vs Tirzepatide: Which Works

While weight loss has been the primary use for GLP-1s, the benefits extend beyond that use

10.1126/scitranslmed.aal2658 90

Others in its drug class like Wegovy, have also seen a surge in demand, one so high that the Food and Drug Administration has reported a national drug shortage for them

Products marketed as GLP-1 vitamins or GLP-1 boosters typically contain ingredients that may marginally increase natural GLP-1 production, but the magnitude of effect does not approach what prescription medications achieve

The reason this section matters even for readers who will never take NNC5840, and most readers will not, because biased-signaling agonists are years from being a consumer choice in this category, is that it changes what next-generation peptide design looks like